Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vinutha Kuchana"'
Autor:
Vinutha Kuchana, Sreekanth Sivan, Sai Kiran Reddy Peddi, Vijjulatha Manga, Vaeshnavi Kashetti
Publikováno v:
Journal of Receptors and Signal Transduction. 42:439-453
B-Raf is one among the most frequently mutating proto-oncogene which is associated with the serine/threonine Raf kinase family involved in the RAS-RAF-MEK-ERK pathway, which is the most deregulated pathway in human cancers. Mutant B-Raf V600E got an
Autor:
Papisetti Venkatesham, Nikhil Ranjan, Anwita Mudiraj, Vinutha Kuchana, Raju Chedupaka, Vijjulatha Manga, Phanithi Prakash Babu, Rajeswar Rao Vedula
Publikováno v:
Bioorganicmedicinal chemistry letters. 80
Glioma is aggressive malignant tumor with limited therapeutic interventions. Herein we report the synthesis of fused bicyclic 1,2,4-triazolothiazoles by a one-pot multi-component approach and their activity against C6 rat and LN18 human glioma cell l
Autor:
Muni Sireesha Sunkara, Vinutha Kuchana, Jahnavi Pragna Sree, Rachana Prabugari, Ashwini Pilli, Farhani Irum, Saritha Jyostna Tangeda, Dipankar Bhowmik
Publikováno v:
Journal of Applied Pharmaceutical Science.
Autor:
Vinutha, Kuchana, Vaeshnavi, Kashetti, Sai Kiran Reddy, Peddi, Sreekanth, Sivan, Vijjulatha, Manga
Publikováno v:
Journal of receptor and signal transduction research. 42(5)
B-Raf is one among the most frequently mutating proto-oncogene which is associated with the serine/threonine Raf kinase family involved in the RAS-RAF-MEK-ERK pathway, which is the most deregulated pathway in human cancers. Mutant B-Raf
Publikováno v:
Trends in Sciences. 20:6403
In US about 106110 diagnosed as melanomas, 7,180 people expected to die due to melanoma. B-RAF is a cytoplasmic serine - threonine kinase that is found in a mutated form in melanoma and colorectal cancer. Sorafenib was initially introduced as a B-RAF